Fundsmith LLP acquired a new stake in shares of Cognex Co. (NASDAQ:CGNX) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 1,033,167 shares of the scientific and technical instruments company’s stock, valued at approximately $39,953,000. Cognex makes up about 0.3% of Fundsmith LLP’s portfolio, making the stock its 25th biggest position. Fundsmith LLP owned approximately 0.60% of Cognex at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. BlackRock Inc. raised its position in Cognex by 0.4% during the third quarter. BlackRock Inc. now owns 17,842,060 shares of the scientific and technical instruments company’s stock valued at $995,944,000 after acquiring an additional 72,784 shares in the last quarter. Vanguard Group Inc. raised its position in Cognex by 0.7% during the third quarter. Vanguard Group Inc. now owns 14,774,139 shares of the scientific and technical instruments company’s stock valued at $824,693,000 after acquiring an additional 101,127 shares in the last quarter. Vanguard Group Inc raised its position in Cognex by 0.7% during the third quarter. Vanguard Group Inc now owns 14,774,139 shares of the scientific and technical instruments company’s stock valued at $824,693,000 after acquiring an additional 101,127 shares in the last quarter. Bank of New York Mellon Corp raised its position in Cognex by 2.7% during the fourth quarter. Bank of New York Mellon Corp now owns 8,760,670 shares of the scientific and technical instruments company’s stock valued at $338,776,000 after acquiring an additional 231,403 shares in the last quarter. Finally, Janus Henderson Group PLC raised its position in Cognex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 4,931,458 shares of the scientific and technical instruments company’s stock valued at $275,296,000 after acquiring an additional 134,103 shares in the last quarter. 94.80% of the stock is currently owned by hedge funds and other institutional investors.

In other Cognex news, Director Theodor Krantz sold 30,000 shares of Cognex stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $53.18, for a total transaction of $1,595,400.00. Following the sale, the director now owns 52,500 shares in the company, valued at $2,791,950. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 5.40% of the stock is owned by insiders.

CGNX traded down $0.58 during trading on Thursday, reaching $52.70. 5,334 shares of the company’s stock were exchanged, compared to its average volume of 1,384,651. Cognex Co. has a fifty-two week low of $34.88 and a fifty-two week high of $59.18. The company has a market capitalization of $9.10 billion, a P/E ratio of 42.63, a P/E/G ratio of 2.79 and a beta of 2.01.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Thursday, February 14th. The scientific and technical instruments company reported $0.26 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.04. Cognex had a net margin of 27.19% and a return on equity of 19.75%. The firm had revenue of $193.29 million for the quarter, compared to the consensus estimate of $184.82 million. During the same quarter in the previous year, the company earned ($0.16) earnings per share. The business’s revenue was up 5.7% compared to the same quarter last year. On average, analysts forecast that Cognex Co. will post 1.26 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 15th. Shareholders of record on Friday, March 1st will be paid a dividend of $0.05 per share. The ex-dividend date is Thursday, February 28th. This represents a $0.20 dividend on an annualized basis and a yield of 0.38%. Cognex’s dividend payout ratio is currently 16.13%.

A number of equities analysts have recently commented on CGNX shares. Zacks Investment Research lowered shares of Cognex from a “buy” rating to a “hold” rating in a research report on Monday, February 4th. Berenberg Bank started coverage on shares of Cognex in a research report on Monday, November 19th. They issued a “buy” rating and a $54.00 price target on the stock. Needham & Company LLC reissued a “buy” rating and issued a $47.00 price target (up previously from $45.00) on shares of Cognex in a research report on Thursday, December 13th. Finally, BidaskClub raised shares of Cognex from a “hold” rating to a “buy” rating in a research report on Thursday, February 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $49.28.

WARNING: “1,033,167 Shares in Cognex Co. (CGNX) Acquired by Fundsmith LLP” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/1033167-shares-in-cognex-co-cgnx-acquired-by-fundsmith-llp/2890377.html.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: Stochastic Momentum Index (SMI)

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.